The company passed the GMP system certification in 2003 as a whole; The leading product vitamin B 1 has passed the quality management system ISO900 1:200 1, food safety management system ISO22000:2005, feed additive and food additive production quality management system Fami-QS and food safety control system HACCP organized by the European Union. "Huayi" trademark became a famous trademark in Hubei Province, and vitamin B 1 product was rated as a famous brand product in Hubei Province. The varieties and specifications are complete, and the leading products are large in scale.
After the reorganization of Tiger Medicine, the company has nearly 300 pharmaceutical preparations in 9 categories, including antibiotics, vitamins, family planning, psychosomatic, cardiovascular and cerebrovascular, hormones, antipyretic and analgesic, and the dosage forms cover tablets, capsules, granules and injections. Among them, the annual production capacity of the leading product vitamin B 1 is the largest manufacturer in the world. The annual production capacity of pharmaceutical preparations is the largest pharmaceutical production enterprise in the province. Wide sales channels and high market share. Raw materials are sold domestically in 28 provinces, municipalities and autonomous regions, exported to more than 20 countries and regions such as the United States, Britain, France, Germany, Southeast Asia and Hong Kong, and listed as inspection-free products in Southeast Asia and Hong Kong markets; Preparation products sell well in more than 20 provinces, municipalities and autonomous regions in China, and are exported to more than 10 countries and regions such as Russia, Africa, Southeast Asia and Cuba. According to the "2 1 1 strategy" and the "Twelfth Five-Year Plan" of China Bingzhuang Group Company, the company has started to fully implement a new round of development strategy-"5321strategy" in the next six years. By 20 15, five product bases will be built on the basis of 2009, and the profit will triple. Huazhong Industrial Park is under construction, which has laid a solid foundation for future development. China Traditional Chinese Medicine Industrial Park, with a total investment of 3 billion yuan, was built by the company to build a billion-dollar pharmaceutical industry in Xiangyang according to the strategic plan of China Bingzhuang Group and Xiangyang to revitalize the pharmaceutical industry. According to the requirements of upgrading equipment, technology and products, the project adopts the mode of "overall planning, rolling development and phased implementation". It is planned to complete the construction of all projects in the industrial park in 20 15, forming five pharmaceutical product bases of vitamins, spirits, antibiotics, antipyretics and analgesics, steroids and finished drugs, and achieving 50% of sales revenue. Facing the future, Huazhong Pharmaceutical keeps up with the development requirements of the times, takes "creating a world-famous brand and building a first-class pharmaceutical enterprise" as the goal, takes Everbright Pharmaceutical and caring for human health as the enterprise purpose, constantly occupies the commanding heights of pharmaceutical technology through technological innovation, and strives to build the company into a large pharmaceutical enterprise group with strong international competitiveness.